期刊文献+

SDC1及其相关蛋白RSPO1、WNT1、p16、WT1的表达对乳腺浸润性导管癌的预后价值分析 被引量:1

Prognostic value of SDC1 and the expression of RSPO1,WNT1,p16,WT1 for invasive ductal carcinoma of breast
下载PDF
导出
摘要 目的:探讨SDC1及相关蛋白在乳腺浸润性导管癌组织中的表达与预后的关系。方法:运用免疫组织化学分析法检测80例乳腺浸润性导管癌患者癌组织中SDC1及其相关蛋白的表达,分析其与临床病理特征的关系。结果:SDC1阳性表达率在雌激素受体阴性表达组显著高于雌激素受体阳性表达组(P=0.033),WT1阳性表达率与肿瘤分期差异具有统计学意义(P=0.024),RSPO1阳性表达率在孕酮受体阳性组显著高于孕酮受体阴性表达组(P=0.015);RSPO1、WT1、p16的阳性表达与无瘤生存率显著相关(P<0.05),且其阳性表达时无瘤生存率较高;RSPO1、p16是影响无瘤生存率的因素,差异有统计学意义(P<0.05);SDC1的阳性表达与WNT1、WT1、p16的阳性表达呈显著正相关(r s>0,P<0.05)。结论:RSPO1和p16蛋白的表达水平可以作为乳腺癌浸润性导管癌的独立预后指标;SDC1与WNT1、WT1、p16在乳腺浸润性导管癌中的表达呈显著正相关。 Objective:To investigate the expression of SDC1 in the tissues of invasive ductal carcinoma of breast and its association with prognosis.Methods:The expression of SDC1,WNT1,WT1,RSPO1 and p16 among 80 invasive ductal carcinoma of breast cases were detected by immunohistochemical method,to explore its association with clinical pathological characteristics.Results:Higher positive expression rate of SDC1 was shown among women who had negative expression of estrogen receptors than those with positive expression of estrogen receptors(P=0.033).The positive expression rate of WT1 was associated with tumor grade(P=0.024),and higher expression rate of RSPO1 was found in women with positive progesterone receptors than those with negative progesterone receptors(P=0.015).The positive expression rate of RSPO1,WT1 and p16 were significantly associated with longer disease-free survival(P<0.05),especially for RSPO1 and p16(P<0.05).Expression of SDC1 were positively associated with WNT1,WT1 and p16(r s>0,P<0.05).Conclusion:Expression of RSPO1 and p16 could be the independent prognostic indicators of invasive ductal cancer of breast.Expression of SDC1were positively associated with the expression of WNT1,WT1,p16.
作者 景文江 马武 马军 Jing Wenjiang;Ma Wu;Ma Jun(Department of Oncology,Hanzhong 3201 Hospital,Shaanxi Hanzhong 723000,China.)
出处 《现代肿瘤医学》 CAS 2019年第21期3808-3812,共5页 Journal of Modern Oncology
基金 陕西省教育厅自然科学研究项目(编号:2013JK0781)
关键词 乳腺浸润性导管癌 SDC1蛋白 预后 invasive ductal carcinoma of breast RSPO1 prognosis
  • 相关文献

参考文献3

二级参考文献23

  • 1Gerdes J, Schwab U, Lemke H, et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation [J]. Iht J Cancer, 1983,31 (1):13-20.
  • 2Hall PA, Levison DA, Woods AL, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms [J]. J Pathol, 1990, 162(4): 285-294.
  • 3Mullerat J, Deroide F, Winslet MC, et al. Proliferation and p53expression in anal cancer precursor lesions [J]. Anticancer Res,2003, 23 (3C): 2995-2999.
  • 4Liu M, Lawson G, Delos M, et al. Predictive value of the fraction of cancer cells immunolabeled for proliferating cell nuclear antigen or Ki67 in biopsies of head and neck carcinomas to identify lymph node metastasis: comparison with clinical and radiologic examinations [J]. Head Neck,2003,25(4): 280-288.
  • 5Tut VM, Braithwaite AL, Angus B, et al. Gyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53,wafl, pRb and Ki67 [J]. Br J Gancer,2001, 84(2): 270-275.
  • 6Bhatavdekar JM, Patel DD, Shah NG,et al. Prognostic significance of immunohisto-chemically localized biomarkers in stage Ⅱ and stage Ⅲ breast cancer: a multivariate analysis [J] . Ann Surg Oncol,2000, 7 (4): 305-311.
  • 7Vincent-Salomon A, Rousseau A, Jouve M, et al. Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapy [J]. Eur J Cancer,2004(40): 1502-1508.
  • 8Nakopoulou L, Stefanaki K, Panayotopoulou E, et al. Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: correlation with proliferation [J]. Hum Pathol,2002,33(9): 863-870.
  • 9Norberg T, Klaar S, Kaff G, et al. Increased p53 nutation frequency during tumor progression-results from a breast cancer cohort [J]. Cancer Res, 2001, 61 (22): 8317-8321.
  • 10Davidoff AM, HerndonJE, Glover NS, et al. Relation between p53overoxpression and established prognostic factors in breast cancer [J]. Surgery, 1991, 110(2): 259-264.

共引文献156

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部